ライブ

FierceBiotechAnalysts cut enGene cancer sales forecast after updated data widen gap to J&J BioPharma DiveFDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended 10x Genomics News10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up - Zacks Investment Research Eli LillyWill Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There. - The Motley Fool AbbottAbbott's Medical Device Strategy Supports Long-Term Growth Outlook - The Globe and Mail FDA News ReleasesFDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics BioPharma DiveLilly, Gilead lead pharma’s M&A boom Endpoints News'Pharma, not really’: Top young AI talent shuns careers at big drugmakers Bio-RadBio-Rad to Participate in Upcoming Investor Conferences - Business Wire PharmaVoiceBiotech layoffs are easing, but is the worst over?Thermo FisherThermo Fisher’s New Cell Therapy Bioreactor And Bioprocess Hub Might Change The Case For Investing In TMO - simplywall.st Eli LillyLilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site - BioSpace

Endpoints News 2026年5月8日

Natalie Holles' next move after Third Harmonic shutdown; Mark Alles passes the torch at ADC biotech

→ It didn’t take long for Natalie Holles to rebound after the decision to wind down operations at her previous company. She has replaced Elisabet de los Pinos a...

→ It didn’t take long for Natalie Holles to rebound after the decision to wind down operations at her previous company. She has replaced Elisabet de los Pinos as CEO of ...